These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2862948)

  • 1. Effects of a selective beta 2-blocker (ICI 118,551) on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Baxter JN; Johnston JN; Devitt P; Shields R
    Br J Surg; 1985 Aug; 72(8):653-6. PubMed ID: 2862948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
    Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
    Jenkins SA; Baxter JN; Corbett WA; Shields R
    Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta adrenergic stimulation and blockade in cirrhosis: effects on azygos vein blood flow and portal hemodynamics.
    Weinshel EH; Altszuler HM; Raicht RF; Sedlis SP
    Am J Med Sci; 1994 Jun; 307(6):396-400. PubMed ID: 7911005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
    Braillon A; Cailmail S; Gaudin C; Lebrec D
    J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
    Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
    J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
    Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
    Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatic artery in haemodynamics in normal and cirrhotic livers in rats.
    Shibayama Y; Nakata K
    J Gastroenterol Hepatol; 1991; 6(6):591-4. PubMed ID: 1782375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.
    Bihari D; Westaby D; Gimson A; Crossley I; Harry J; Williams R
    Br J Clin Pharmacol; 1984 Jun; 17(6):753-7. PubMed ID: 6146330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of carbon dioxide pneumoperitoneum on hemodynamics in cirrhotic rats.
    Tsuboi S; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Baatar D
    Surg Endosc; 2002 Aug; 16(8):1220-5. PubMed ID: 11984669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.
    Vasina V; Giannone F; Domenicali M; Latorre R; Berzigotti A; Caraceni P; Zoli M; De Ponti F; Bernardi M
    Br J Pharmacol; 2012 Nov; 167(5):1137-47. PubMed ID: 22708587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
    Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
    J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
    Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
    Fukuda T; Narahara Y; Kanazawa H; Matsushita Y; Kidokoro H; Itokawa N; Kondo C; Atsukawa M; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2014 Feb; 29(2):325-9. PubMed ID: 24033356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of terbutaline, a beta 2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis.
    Poo JL; Braillon A; Hadengue A; Gaudin C; Lebrec D
    Hepatology; 1992 Mar; 15(3):459-63. PubMed ID: 1347507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.